Register entry

PENN PHARMACEUTICALS LIMITED

Data as of · How to read this entry

Registered sites
1
Active NDC listings
24
Labeller names
4
Live patents
0
Countries
1
Base
United Kingdom
Authorisation

Registered operations

Analytical testing1Labelling1Finished drug manufacture1Packaging1
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
PENN PHARMACEUTICAL SERVICES LIMITEDRegistrant: PENN PHARMACEUTICALS LIMITED23-24 Tafarnaubach Industrial Estate, Tafarnaubach, Tredegar, NP22 3AA, United Kingdom (GBR)Analytical testing, Labelling, Finished drug manufacture, Packaging1000370240226277259
Catalogue

Drug listings by form and route

24

24 active NDC listings: 24 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 24.

Dosage formNDCs
tablet, film coated12
capsule5
tablet4
liquid2
solution1
RouteNDCs
Labeller name on the listingNDCs
penn pharmaceutical services limited9
penn pharmaceutical services limited9
penn pharmaceutical services ltd5
penn pharmaceutical services ltd1
Catalogue

Marketed products

24
BrandGeneric nameForm / routeNDC
-Etrasimodtablet, film coated63069-052DRUG FOR FURTHER PROCESSING
-FENFLURAMINE HYDROCHLORIDEsolution63069-525DRUG FOR FURTHER PROCESSING
-FUTIBATINIBtablet63069-101DRUG FOR FURTHER PROCESSING
-MACITENTAN and TADALAFILtablet, film coated63069-102DRUG FOR FURTHER PROCESSING
-MACITENTAN and TADALAFILtablet, film coated63069-103DRUG FOR FURTHER PROCESSING
-OSILODROSTAT PHOSPHATEtablet, film coated63069-107DRUG FOR FURTHER PROCESSING
-OSILODROSTAT PHOSPHATEtablet, film coated63069-108DRUG FOR FURTHER PROCESSING
-OSILODROSTAT PHOSPHATEtablet, film coated63069-109DRUG FOR FURTHER PROCESSING
-OSPEMIFENEtablet, film coated63069-601DRUG FOR FURTHER PROCESSING
-VANDETANIBtablet, film coated63069-782DRUG FOR FURTHER PROCESSING
-VANDETANIBtablet, film coated63069-784DRUG FOR FURTHER PROCESSING
-glycerol phenylbutyrateliquid63069-106DRUG FOR FURTHER PROCESSING
-larotrectinibcapsule63069-390DRUG FOR FURTHER PROCESSING
-larotrectinibcapsule63069-391DRUG FOR FURTHER PROCESSING
-larotrectinibliquid63069-392DRUG FOR FURTHER PROCESSING
-nitisinonetablet63069-071DRUG FOR FURTHER PROCESSING
-nitisinonetablet63069-072DRUG FOR FURTHER PROCESSING
-nitisinonetablet63069-075DRUG FOR FURTHER PROCESSING
-pomalidomidecapsule63069-402DRUG FOR FURTHER PROCESSING
-pomalidomidecapsule63069-403DRUG FOR FURTHER PROCESSING
-pomalidomidecapsule63069-404DRUG FOR FURTHER PROCESSING
-sarecycline hydrochloridetablet, film coated63069-245DRUG FOR FURTHER PROCESSING
-sarecycline hydrochloridetablet, film coated63069-246DRUG FOR FURTHER PROCESSING
-sarecycline hydrochloridetablet, film coated63069-247DRUG FOR FURTHER PROCESSING
Compare

Comparable companies in United Kingdom

Enquiry

Common questions

Is PENN PHARMACEUTICALS LIMITED FDA approved?
PENN PHARMACEUTICALS LIMITED holds 1 FDA-registered establishment in the United Kingdom. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are PENN PHARMACEUTICALS LIMITED's drugs manufactured?
The FDA register lists Tredegar. Registered operations: analytical testing, labelling, finished drug manufacture, packaging.
What drugs does PENN PHARMACEUTICALS LIMITED make?
24 products are listed under PENN PHARMACEUTICALS LIMITED in the openFDA NDC Directory, most often as tablet, film coated; capsule; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.